ArticleTherapeutic advances in medical oncology2024

Exceptional synergistic response of PARP inhibitor and immune checkpoint inhibitor in esophageal adenocarcinoma with a germline BRCA2 mutation: a case report.

Himil Mahadevia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.